FDA inspection
BioReliance Corporation: FDA inspection ending Jul 13, 2018
FDA inspection 1059115 · Voluntary Action Indicated (VAI) · Rockville, MD
Key facts
| Inspection ID | 1059115 |
|---|---|
| Firm | BioReliance Corporation |
| FEI number | 1122041 |
| Address | 14920 Broschart Rd |
| City | Rockville |
| State | MD |
| ZIP | 20850 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Jul 13, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data